← FDA Drug Approvals (Drugs@FDA)
Tofacitinib
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: YAOPHARMA CO LTD · Approved 2022-10-04
Drug application
- FDA Application #
ANDA215552- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- Tofacitinib
- Generic name
- Tofacitinib
- Active ingredients
- Tofacitinib
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- YAOPHARMA CO LTD
- First approval
- 2022-10-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown